Over the last few days, acquisition suitors of bluebird bio sweetened their offer, RA Capital and Khosla Ventures launched a ...

Fusion energy startup Realta Fusion today announced an oversubscribed $36 million Series A round to bring its compact, scalable, modular magnetic mirror fusion technology closer to ...

Neale Daniher has focused the nation on finding a cure for motor neurone disease (MND). That cure has not been found, but if ...

Eight Sleep Inc., a startup known for its high-tech, temperature-controlled mattress covers and systems, released an expanded ...

Cambridge, USA-based biotech Stylus Medicine, which says it is dedicated to developing transformative in vivo genetic ...

Stylus will use the Eli Lilly and J&J-backed funds to advance its in vivo genetic medicines platform and develop its pipeline ...

Somite AI, a TechBio company leveraging foundation models and proprietary AI to accelerate human cell therapy development, closed its Series A funding round, raising more than $47 million. The round ...

Cell therapy development company Somite AI has announced the completion of a $47 million Series A financing round led by ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

The company hopes to make sufficient progress this year and next so it can pitch investors on a Series B, which would go ...

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that it has signed an agreement ...